Georgian Medical Journal (GMJ)
Not a member yet
62 research outputs found
Sort by
The People’s Vaccine: How a COVID-19 Vaccine Will Be a Test of Global Accountability and Equity (BMJ Opinion, 2020): Reference Summary (Article)
No full textThis reference summary presents key information from the following article: https://blogs.bmj.com/bmj/2020/12/15/the-peoples-vaccine-how-a-covid-19-vaccine-will-be-a-test-of-global-accountability-and-equity/. The source is an opinion article titled “The people’s vaccine: how a COVID-19 vaccine will be a test of global accountability and equity”, authored by Phumaphi J, Killen B, Pkhakadze G, Mason E, and published in BMJ Opinion on 15 December 2020. The article highlights the unprecedented global health and economic impact of COVID-19 and emphasizes that equitable access to vaccines is a defining test of global accountability. It underscores that low- and middle-income countries face significant structural and financial barriers to vaccine access, despite representing the majority of the global population. The discussion stresses the importance of universal health coverage (UHC), strong primary health care systems, and sustained global cooperation, including initiatives such as COVAX, to ensure fair vaccine distribution. These principles align with the framework advanced by the United Nations Secretary-General’s Independent Accountability Panel for Every Woman, Every Child, Every Adolescent (IAP: Nicholas Kojo Alipui, Dame Carol Kidu, Brenda Killen, Elizabeth Mason, Giorgi Pkhakadze, Jovana Ríos Cisnero, Gita Sen, Alicia Ely Yamin, Kul Chandra Gautam, and Joy Phumaphi), reinforcing that accountability, transparency, and equity are essential to ensure that no one is left behind. The article concludes that global cooperation and rights-based approaches will determine whether the pandemic is addressed collectively and equitably
Metabolic Dysfunction and Acne Severity: Mechanisms and Clinical Implications
No full textBackground:Acne vulgaris is one of the most common dermatological disorders worldwide and remains a frequent cause of clinical consultation in both adolescents and adults. Although traditionally understood as a disease of the pilosebaceous unit driven by androgen activity, follicular hyperkeratinization, sebaceous gland dysfunction, microbial imbalance, and inflammation, increasing evidence suggests that systemic metabolic disturbances may also contribute to disease severity and persistence [1–6]. In particular, insulin resistance, insulin-like growth factor-1 (IGF-1) signaling, adiposity, dyslipidemia, and hyperandrogenic states have emerged as potentially relevant modifiers of acne pathophysiology [7–11].
Objective:To synthesize and critically evaluate current evidence linking acne severity with multiple domains of metabolic dysfunction, including insulin resistance, IGF-1 signaling, obesity-related pathways, lipid abnormalities, and endocrine dysregulation, and to assess their clinical relevance for dermatology practice [12–19].
Methods:A systematized review with narrative synthesis was conducted using PubMed/MEDLINE, Embase, Scopus, Web of Science, and Cochrane Library. Studies published between January 2000 and March 2026 were screened using predefined eligibility criteria. Observational, interventional, and mechanistic clinical studies evaluating associations between acne and metabolic parameters were considered. Data were extracted on study design, population characteristics, acne severity measures, metabolic exposures, and key outcomes. Methodological quality was appraised using appropriate tools, and evidence was synthesized across predefined metabolic domains rather than pooled quantitatively because of substantial heterogeneity in study designs, populations, and definitions [12–19].
Results:Current evidence suggests an association between acne severity and several forms of metabolic dysfunction, with the most consistent findings observed for insulin resistance and related glucose metabolism abnormalities [12–19]. Mechanistic studies support the role of IGF-1 activation, mammalian target of rapamycin complex 1 (mTORC1) signaling, and reduced sex hormone-binding globulin in increasing androgen bioavailability, sebaceous gland activity, and inflammatory responses [20–27]. Obesity and altered body composition may further modulate acne through adipokine imbalance and chronic low-grade inflammation, although findings are not consistent across all studies [28–32]. Dyslipidemia has also been reported in acne populations, but results remain heterogeneous and are influenced by methodological variability and potential treatment-related confounding [33–37]. In contrast, evidence linking acne directly to formally defined metabolic syndrome is less consistent than evidence linking acne to its individual metabolic components [7–11,44–47].
Conclusion:Acne vulgaris should not be reclassified as a metabolic disorder; however, available evidence indicates that acne severity may be influenced by broader systemic metabolic and endocrine processes, particularly insulin resistance and IGF-1–mediated pathways [12–27]. The relationship with formal metabolic syndrome remains heterogeneous and insufficiently established [7,14,44–47]. These findings support a more integrated dermatological approach in selected high-risk patients, especially those with severe, persistent, treatment-resistant, or hormonally influenced acne. Further longitudinal and interventional studies are needed to clarify causality and define the role of targeted metabolic evaluation and intervention in acne management [12,26,38,44–47]. These findings highlight the importance of considering metabolic factors in selected patients with moderate-to-severe or treatment-resistant acne.
Keywords: Acne vulgaris; Insulin resistance; Metabolic dysfunction; IGF-1; mTOR; Dyslipidemia; Obesity; Polycystic ovary syndrome
Tskaltubo and the Future of Structured Spa-Based Therapeutic Systems: Integrating Radon Balneotherapy, Rehabilitation, and Preventive Health in Evidence-Based Care
No full textThe global rise in chronic non-communicable diseases, population ageing, and healthcare system fragmentation has intensified the need for integrated, non-pharmacological approaches to rehabilitation, recovery, and preventive health. Among these, spa medicine and balneotherapy have re-emerged as potentially valuable yet under-theorized and insufficiently standardized components of modern healthcare systems.
This commentary introduces the concept of structured spa-based therapeutic systems (SSTS) as a framework for understanding spa medicine as a coordinated, multimodal intervention rather than a collection of isolated treatments. SSTS combine natural therapeutic resources, standardized exposure conditions, environmental design, and behavioral structuring within a unified system of care. Using the Tskaltubo spa system in Georgia as a case example, this paper examines how such models can be critically evaluated and positioned within contemporary evidence-based healthcare.
Radon balneotherapy, a defining component of several spa systems, presents a unique clinical and regulatory challenge. While low-dose exposure has been associated with anti-inflammatory, analgesic, and immunomodulatory effects, radon remains a recognized carcinogen, raising important questions regarding dose–response relationships, cumulative exposure, and long-term safety. Current clinical evidence suggests meaningful benefits in selected conditions—particularly musculoskeletal disorders and rehabilitation contexts—but remains heterogeneous, methodologically limited, and insufficient for clinical standardization.
This paper argues that SSTS represent an underutilized, structured intervention platform with potential relevance for modern healthcare, particularly in rehabilitation, chronic disease management, and preventive health. However, their integration requires rigorous clinical validation, mechanistic clarification, and the development of dedicated regulatory frameworks, including standardized exposure protocols, patient selection criteria, and long-term monitoring systems. By bridging traditional spa medicine with contemporary scientific and health system perspectives, this work provides a foundation for the systematic and responsible integration of spa-based therapeutic environments into evidence-based care.
Keywords: Balneotherapy; Radon therapy; Low-dose radiation; Integrative medicine; Preventive health; Rehabilitation; Structured therapeutic systems; Tskaltub
Launch of the UN Secretary-General’s Independent Accountability Panel (IAP) 2018 Report: Reference Summary (Video)
No full textThis reference summary presents key information from the following presentation:
https://webtv.un.org/en/asset/k1s/k1sdjzyfpx.
The source is a United Nations Web TV recording titled “Launch of the UN Secretary-General’s Independent Accountability Panel for Every Woman, Every Child, Every Adolescent 2018 Report,” held on 27 September 2018 at United Nations Headquarters in New York during the United Nations General Assembly. The event presents the findings and recommendations of the Independent Accountability Panel (IAP), which is mandated by the United Nations Secretary-General to conduct annual independent reviews of progress on the Global Strategy for Women’s, Children’s and Adolescents’ Health (2016–2030). The 2018 report focuses on the theme of private sector accountability, examining the role and responsibilities of private sector actors in global health. The presentation includes remarks by IAP leadership and contributions from a multi-stakeholder audience, including representatives of Member States, United Nations agencies, civil society, and other partners
Launch of the Independent Accountability Panel (IAP) 2017 Report: Reference Summary (Video)
No full textThis reference summary presents key information from the following presentation:
https://webtv.un.org/en/asset/k1e/k1ehopir59.
The source is a United Nations Web TV recording titled “Launch of the Independent Accountability Panel (IAP) 2017 Report,” held on 18 September 2017 at United Nations Headquarters in New York. The event presents the findings and recommendations of the Independent Accountability Panel (IAP), which is mandated by the United Nations Secretary-General to conduct annual independent reviews of progress on the Every Woman Every Child Global Strategy for Women’s, Children’s and Adolescents’ Health (2016–2030). The 2017 report focuses on the theme of transformative accountability for adolescents. The presentation includes remarks by IAP co-chairs and a high-level panel discussion, followed by interactive engagement with representatives of Member States, United Nations agencies, donors, health professionals, civil society, and youth stakeholders
Celebrating 10 Years of Every Woman Every Child — UN High-Level Event, New York, USA (23 September 2020, EWEC): Reference Summary (Video)
No full textThis reference summary presents key information from the following presentation: https://youtu.be/mKjti0l0HwY. The source is a video titled “Celebrating 10 Years of Every Woman Every Child”, produced by Every Woman Every Child (EWEC) and published on 23 September 2020. The event took place in New York, USA, and marks a decade of global action to improve the health and well-being of women, children, and adolescents. The session brings together global leadership messages highlighting progress achieved under the EWEC initiative and the importance of sustained commitment, accountability, and partnership in advancing the Sustainable Development Goals (SDGs). It emphasizes the need to accelerate efforts, strengthen health systems, and ensure equitable outcomes, particularly in the context of global challenges such as COVID-19, with a continued focus on leaving no one behind
The Power of Modern Public Health in Practice: A Georgian Case Commentary on Risk Communication, Digital Health Ecosystems, and Regulatory Action During the Global Nestlé Infant Formula Recall (January 2026)
No full textIn January 2026, Nestlé initiated a voluntary recall of selected infant and follow-on formula products following identification of a potential safety concern related to cereulide, a heat-stable emetic toxin produced by some strains of Bacillus cereus, associated in public reporting with a quality issue in an upstream ingredient (arachidonic acid oil, ARA) supplied by a third party [1–3]. Within days, recall actions and official warnings expanded across continents. By 9 January 2026, international media and food-safety reporting indicated that more than 50 countries and market jurisdictions had issued recalls or public warnings [2–4].
Despite this escalation, Georgia was not listed on Nestlé’s official global advisory webpage as accessed on 8–9 January 2026, which explicitly states that its list of affected countries is “not exhaustive” [5]. Nevertheless, on 8 January 2026 the National Food Agency of Georgia publicly confirmed the supervised withdrawal of specific infant formula batches from the Georgian market and issued consumer warnings, disseminated by national broadcasters and news agencies [6–8].
This commentary presents the Georgian response as a case study demonstrating how modern public health—through evidence synthesis, rapid translation, independent digital health platforms, algorithm-aware dissemination, and institutional engagement—can shorten time-to-protection in the context of multinational corporate information asymmetry
Every Woman Every Child COVID-19 Expert Series — Commitment and Accountability with Joy Phumaphi (EWEC, 2020): Reference Summary (Video)
No full textThis reference summary presents key information from the following presentation: https://youtu.be/yf0mESTxP9o. The source is a video titled “Every Woman Every Child COVID-19 Expert Series: Commitment & Accountability with Joy Phumaphi”, produced by Every Woman Every Child (EWEC) and published in 2020. The session features Joy Phumaphi, Co-Chair of the United Nations Secretary-General’s Independent Accountability Panel (IAP), and focuses on the importance of accountability in delivering on commitments to improve the health and well-being of women, children, and adolescents during the COVID-19 pandemic. The discussion emphasizes the need to translate commitments into action, strengthen accountability mechanisms, and ensure that progress is sustained despite the challenges posed by the pandemic, with particular attention to equity and the principle of leaving no one behind
Infant Formula Contamination as a Systemic Failure of Global Food Safety Governance: Lessons from the 2025–2026 Cereulide Outbreak
No full textInfant formula is among the most tightly regulated food products globally, yet repeated contamination events continue to expose critical weaknesses in food safety governance. The 2025–2026 multi-country contamination involving cereulide toxin in infant formula, distributed across nearly one hundred countries with over 100 suspected and confirmed infant illness cases, represents a sentinel event.
This commentary situates the cereulide outbreak within a broader pattern of recurrent crises, including the 2008 melamine contamination in China, the 2017–2018 Salmonella outbreak in France, and the 2022 Cronobacter-related disruption in the United States. Across these events, consistent structural failures are observed: upstream supply chain opacity, fragmented recall systems, delayed detection and communication, and persistence of contaminated products at the household level.
These patterns indicate that infant formula contamination is not an isolated anomaly but a predictable outcome of fragmented and reactive global food safety systems. The cereulide event further highlights emerging risks related to heat-stable toxins not mitigated by standard preparation practices.
Addressing these failures requires a transition toward proactive, globally coordinated governance, including real-time international recall systems, enhanced upstream traceability, mandatory rapid disclosure, and direct-to-consumer risk communication. Protecting infants requires structural reform rather than incremental adjustments.
Keywords: Infant formula; Food safety governance; Cereulide toxin; Bacillus cereus; Global food systems; Supply chain risk; Food recall systems; Risk communication; Public health policy; Infant healt
From Page to Action: Accountability for the Furthest Left Behind in COVID-19 & Beyond — IAP 2020 Report Launch (HLPF Side Event): Reference Summary (Video)
No full textThis reference summary presents key information from the following presentation:
https://webtv.un.org/en/asset/k1b/k1bjv4y4i9.
The source is a United Nations Web TV recording titled “From Page to Action: Accountability for the Furthest Left Behind in COVID-19 & Beyond. Launch of the 2020 Report of the UN Secretary-General’s Independent Accountability Panel (IAP) for Every Woman Every Child,” held on 13 July 2020 as a High-level Political Forum (HLPF) side event. The presentation highlights the launch of the IAP’s 2020 report, “Caught in the COVID-19 storm: progress and accountability,” which examines health outcomes for women, children and adolescents in the context of universal health coverage and the Sustainable Development Goals. The event was co-hosted by the Governments of Japan, South Africa and Georgia and co-organized by the Every Woman Every Child Secretariat, the IAP, UHC2030 and the Partnership for Maternal, Newborn and Child Health (PMNCH). It includes presentations and discussions involving global leaders, policymakers and stakeholders, emphasizing accountability as a critical tool to protect vulnerable populations and ensure progress despite the COVID-19 pandemic